Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amendment: NAV Announcement and Portfolio Update

25 Jun 2019 15:57

RNS Number : 3917D
Adamas Finance Asia Limited
25 June 2019
 

25 June 2019

 

The following amendment has been made to the 'Unaudited NAV Announcement and Portfolio Update' released on 25 June 2019 at 07:00 under RNS 2412D.

The original announcement was denominated in USD values. Following the redenomination of Adamas Finance Asia Limited's Ordinary Shares into Pounds Sterling announced on 21 June 2019 under RNS 9510C, all values in this announcement have been changed to Pound Sterling to reflect this.

All other details remain unchanged.

The full amended text is shown below.

 

ADAMAS FINANCE ASIA LIMITED

(the "Company" or "ADAM")

 

31 March 2019 Unaudited NAV Announcement and Portfolio Update

 

NET ASSET VALUE

Adamas Finance Asia Limited (AIM: ADAM), the London quoted pan-Asian diversified investment vehicle, is pleased to announce its quarterly net asset value ("NAV") update.

As at 31 March 2019, the consolidated unaudited estimated NAV per share was US$1.10/GBP0.86 per share. The Company has used the USD:GBP (US$1.00:GBP0.78) exchange rate as at 24 June 2019 to determine the GBP values.

Since 31 December 2018, the NAV per share has decreased by 5.1% primarily due to the issuance of new shares as announced on 13 February 2019. The total number of shares outstanding as at 31 March 2019 was 88,733,069 ordinary shares, of which, 87,896,265 ordinary shares have voting rights and 836,804 ordinary shares are held in treasury.

UPDATE ON KEY INVESTMENTS

Hong Kong Mining Holdings Limited ("HKMH")

On 6 March 2019, the Company announced an update on activity to restart production at HKMH's mining site in Shanxi Province, China. Workers have been active on-site and key management personnel have been appointed. The management team have been sourcing mining equipment such as crushing machines and conveyor belts to re-start operations. Furthermore, the onshore team have been in detailed discussions with mining contractors to outsource mining activities. However, due to minor regulatory delays, the Company advises that production is expected to recommence in the second half of 2019. HKMH is working closely with the local government to overcome any unanticipated delays.

Fook Lam Moon Holdings ("FLMH")

On 21 January 2019, FLMH was awarded "Chinese Restaurant of the Year 2019" in the recently-published "Top 100 Chinese Restaurants of the World". In this particular ranking, restaurants in 26 cities around the world are judged by an international panel of food critics based on their "Quality of Food", "Consistency of Quality", "Authenticity" and "Creativity". In the same month, FLMH launched a new VIP program designed to deliver year-round dining and lifestyle privileges to regular patrons at the restaurant's various outlets.

DocDoc Pte Ltd ("DocDoc")

In February 2019, the Hong Kong Cyberport Management Company Limited ("Cyberport") announced that its venture capital investment arm, Cyberport Macro Fund, has invested US$2.0MM/GBP1.6MM in DocDoc. Following this investment, DocDoc will open a new office in Hong Kong's Cyberport, a technology-focused business complex and start-up incubator. This recent investment from Cyberport Macro Fund brings the total funding DocDoc has raised to date to US$18.5MM/GBP14.5MM.

Infinity Capital Group Limited ("ICG")

On 31 January 2019, ADAM completed the first tranche of its investment in ICG. In February 2019, ICG announced that it has officially opened a flagship TELLUS showroom in Niseko, Japan - the first overseas location established by ICG since inception in 2015. ICG anticipates the opening of this showroom will facilitate new opportunities for exchange and collaboration with shareholders and potential buyers.

Further details of the Company and its investments are available on the Company's website www.adamasfinance.com 

Enquiries: 

 

Adamas Finance Asia Limited +44 (0) 1825 830587 

John Croft 

 

 

WH Ireland Limited - Nominated Adviser 

+44 (0) 20 7220 1666 

James Joyce 

James Sinclair Ford 

 

 

 

VSA Capital Limited - Corporate Broker 

+44 (0) 20 3005 5000 

Andrew Monk 

Andrew Raca 

 

 

Buchanan - Financial PR 

Charles Ryland 

Victoria Hayns 

Henry Wilson 

 +44 (0) 20 7466 5000 

 

About Adamas Finance Asia 

ADAM is a London quoted investment company focusing on delivering long-term income and capital growth to shareholders through a diverse portfolio of pan-Asian investments. It aims to provide uncorrelated returns through a combination of capital growth and dividend income from a broad spectrum of national geographies and asset classes from the Asian Small and Medium Enterprise (SME) sector. 

 

The company's investment manager, Harmony Capital, which has a dedicated team with real Asian expertise, is focussed on the strategy of creating income and capital growth. Harmony is sourcing predominately private opportunities and has created a strong pipeline of income generating assets from potential investments in industries such as healthcare, fintech, hospitality, IT and property across Asia. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCDMGZVDKLGLZM
Date   Source Headline
24th Oct 201810:24 amRNSNet Asset Value Update
16th Oct 201810:34 amRNSDirector/PDMR Shareholding
13th Sep 20187:00 amRNSInterim Results for Six Months Ended 30 June 2018
17th Aug 201811:43 amRNSResult of AGM
13th Aug 201810:50 amRNSNet Asset Value Update
26th Jul 201812:06 pmRNSNet Asset Value Update
23rd Jul 20189:44 amRNSDisposal of Interest in Global Pharm
11th Jul 201810:38 amRNSResult of General Meeting
28th Jun 20183:50 pmRNSPosting of Annual Report and Accounts
21st Jun 20187:00 amRNSAppointment of Broker
21st Jun 20187:00 amRNSFinal Results for the Year Ended 31 December 2017
15th Jun 20188:36 amRNSDisposal of Interest in Global Pharm & GM Notice
27th Apr 20187:00 amRNSUpdate on Disposal of Interest in Global Pharm
26th Apr 20181:57 pmRNSResult of General Meeting
20th Apr 20188:49 amRNSDirector/PDMR Shareholding
5th Apr 20183:54 pmRNSDisposal and Notice of General Meeting
29th Mar 20187:00 amRNSUpdate on Disposal of Interest in Global Pharm
26th Mar 20184:44 pmRNSIncreased Ownership in HKMH
19th Mar 20187:00 amRNSNew Investment
8th Feb 201812:17 pmRNSUpdate - Net Asset Value
2nd Feb 20188:24 amRNSDirector/PDMR Shareholding
15th Jan 20187:00 amRNSFurther re. Disposal of Interest in Global Pharm
21st Dec 20178:54 amRNSIncrease in Shareholding in Hong Kong Mining
31st Oct 201710:23 amRNSNet Asset Value Update
2nd Oct 20177:00 amRNSAppointment of Director
22nd Sep 20177:00 amRNSInterim Results For Six Months End 30 June 2017
20th Sep 201711:18 amRNSAGM and Share Consolidation
15th Sep 20177:00 amRNSDisposal of Interest in Global Pharm
30th Aug 20174:50 pmRNSProposed Share Consolidation
4th Aug 20173:36 pmRNSUpdate on Global Pharm Convertible Bond
27th Jul 20177:00 amRNSNet Asset Value(s)
20th Jul 20179:43 amRNSDirectorate Change
20th Jul 20179:27 amRNSAnnual General Meeting
3rd Jul 20179:14 amRNSAppointment of Director
29th Jun 201710:45 amRNSFinal Results
22nd Jun 20178:46 amRNSFurther Payment of Proceeds for TTS Disposal
15th Jun 20179:43 amRNSPayment of Proceeds for TTS Project Disposal
25th May 201711:06 amRNSResult of Meeting
2nd May 20177:00 amRNSChange of Investment Manager and Investing Policy
24th Feb 201711:45 amRNSUPDATE ON TTS PROJECT DISPOSAL
8th Feb 20179:26 amRNSUPDATE ON TTS PROJECT DISPOSAL
31st Jan 20177:00 amRNSDistribution from GCCF
23rd Jan 20179:15 amRNSUPDATE: REDEMPTION OF GLOBAL PHARM CONVERTIBLE
13th Jan 20178:15 amRNSUPDATE ON TTS PROJECT DISPOSAL
4th Jan 20179:00 amRNSProposed Disposal
29th Dec 20167:00 amRNSDirector/PDMR Shareholding
22nd Dec 20161:18 pmRNSDirector/PDMR Shareholding
20th Dec 20164:19 pmRNSDirector/PDMR Shareholding
13th Dec 20169:23 amRNSDirector/PDMR Shareholding
6th Dec 201612:34 pmRNSCorrection to Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.